WELCOME! 12/13/2018. Today s Topic: Urine Drug Screens in OUD Treatment UW PACC

Similar documents
URINE DRUG TOXICOLOGY

Controlled Substance Monitoring in the Age of the Opioid Epidemic

Urine Drug Testing. Methadone/Buprenorphine 101 Workshop. Ron Joe, MD, DABAM December 10, 2016

Testing for Controlled Substances

Patient-Centered Urine Drug Testing. Douglas Gourlay, MD, MSc, FRCPC, FASAM

OPIOIDS: ENGAGING PATIENTS IN OUD TREATMENT

Urine Drug Testing Methods 3-5

Frequently Asked Questions: Opiate Dependency and Methadone Maintenance Treatment program follow-up

3/8/2018. Reasons for Doing UDT. UDT: A Tool in Risk Assessment. Faculty/Presenter Disclosure. Urine Drug Testing in Chronic Pain Management

Urine drug testing it s not always crystal clear

The Utility of Urine Drug Screening

Clinical Policy: Outpatient Testing for Drugs of Abuse Reference Number: PA.CP.MP.50

Quest Diagnostics Drug Testing Index Full Year 2015 Tables

Controlled Substances Evidence-based Tips for Improved Workflow: Diagnosis, Screening & Drug Testing

Urine Drug Testing to Monitor Opioid Use In Managing Chronic Pain

The Drug Testing Process. Employer or Practice

Learning Objectives. Drug Testing 10/17/2012. Utilization of the urine drug screen: The good, the bad, and the ugly

Overview of the AACC Academy s LMPG: Using clinical laboratory tests to monitor drug therapy in pain management patients

Overview. Opioids and HIV Infection: From Pain Management to Addiction Treatment

USE OF BUPRENORPHINE FOR CHRONIC PAIN

Your Results are Our Priority.

Conflict of Interest Disclosure

Lyndsey Knoy, D-ABFT-FT Forensic Scientist Washington State Toxicology Laboratory.

Linking Opioid Treatment in Primary Care. Roxanne Lewin M.D.

Drug Screening: Things You Need to Know

Gold Standard for Urine Drug Testin Urine Drug Testing Why U rine? Urine?

Caring for ME Webinar: Urine Drug Screening Speaker: Dr. Jonathan Fellers Tuesday, November 20, PM

Workforce Drug Testing Positivity Climbs to Highest Rate Since 2004, According to New Quest Diagnostics Analysis

1/27/ New Release, Quest Diagnostics Nichols Institute, Valencia

Contract No. 952-M1 Collection Service Requirements Texas Department of Criminal Justice (TDCJ)

Drug Testing Basics. by Erowid

Welcome! Supreme Court of Ohio Specialized Dockets Conference. October 23-24, 2017

Prescription Drug Impact in the Workplace

Evaluation of the Impact of Expanding ELISA Screening in DUID Investigations. Aileen Lu*, Karen S. Scott, Aya Chan-Hosokawa, and Barry K.

Best Practices in Prescribing Opioids for Chronic Non-cancer Pain

Alcohol. Ethanol Highlands Parkway, Suite 100 Smyrna, GA 30082

MEDICAL POLICY Drug Testing

September HCMC Toxicology Transition: Additional information and Frequently Asked Questions

PROFESSIONALISM AND COMMENTARY. Optimizing Urine Drug Testing for Monitoring Medication Compliance in Pain Management

EDUCATIONAL COMMENTARY rd TEST EVENT Chemistry Urine Drug Testing

Analysis and interpretation of drug testing results from patients on chronic pain therapy: a clinical laboratory perspective

Clinical Policy: Outpatient Testing for Drugs of Abuse Reference Number: PA.CP.MP.50

MEDICAL POLICY No R2 DRUG TESTING

Cutoff levels for hydrocodone in a blood test

Pharmacology of Addic0ve Disorders

B. To assess an individual when clinical evaluation suggests use of non-prescribed medications or illegal substances; or

What Your Drug Test Really Means. Krista Beiermann, RN, OHS Occupational Health Services, Columbus Hospital

Pain Management Drug Testing: A Laboratory Perspective

A brief history of urine drug testing. Forging a common vocabulary for urine drug testing

Effective Date: Approved by: Laboratory Executive Director, Ed Hughes (electronic signature)

Laboratory Testing to Support Pain Management: Methods, Concepts and Case Studies

Does ultram show up as an opiate

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot

Screening Pregnant and Postpartum Women for Substance Use Disorder. MPQC Fall Summit November 14, 2018

MEDICAL POLICY Drug Testing

Disclosures. Get Your Specimens in Order:

Urine Drug Testing In Pain Management and Substance Abuse Treatment Corporate Medical Policy

Disclosures. You're in Control or Urine Control Clinical Pearls of Drug Testing Case Studies. 9/20/17

MEDICATION ALGORITHM FOR ANXIETY DISORDERS

FEP Medical Policy Manual

AN INTRODUCTION TO THE TREATMENT OF OPIOID USE DISORDERS IN PRIMARY CARE

Community Drug Early Warning System (CDEWS-3): Washington, DC - Site 3 of 4

Cross-reactivity reactivity in EMIT

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot

Urine Drug Screening: The Essentials of Interpretation

EDUCATIONAL COMMENTARY METHADONE

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot

Drug Testing in Pain Management and Substance Use Disorder Treatment

ORAL FLUID AS A CHEMICAL TEST FOR THE DRE PROGRAM : HISTORY, THE FUTURE, AND PRACTICAL CONSIDERATIONS

Clinical Policy: Outpatient Testing for Drugs of Abuse

Forensic Toxicology Scope of Testing and Detection Limits

How Can a Methadone and an Opiate-Positive Immunoassay Result be Reconciled in a Patient Prescribed only OxyContin and Wellbutrin?

Drug Profiles of Apprehended Drivers in Victoria

The Drug Evaluation and Classification Program

Workforce Drug Positivity at Highest Rate in a Decade, Finds Analysis of More Than 10 Million Drug Test Results

Test Definition: PDSOX Pain Clinic Drug Screen, Chain of Custody, Urine

PACIFICSOURCE COMMUNITY SOLUTIONS AND GORGE COORDINATED CARE ORGANIZATION. Chronic Pain and Opiate Management Initiatives

..,5_,'11, Substance Use and Child Welfare { .., l , 22,

nextgen precision Test Report

10/16/2017. Objectives. Drug Testing Interpretation in Addiction Care. Background. Which is Nonadherent?

Based on our criteria and assessment of the peer-reviewed literature, presumptive (immunoassay) in office or pointof-care

MANAGING DISTRESS TOLERANCE - HOW CAN I IMPROVE MY PATIENT'S DISTRESS TOLERANCE?

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot

Many companies conduct drug screenings. But you better avoid the following nine items and save yourself a world of frustration, if you need

Drug Screening. Separating Facts from Myths

DrugConfirm Advanced Instant Urine Drug Test Cups Training Guide.

3703 Camino del Rio South 100-A San Diego, CA, Phone Fax CLIA# 05D years

5/15/2017. Neglect. Potpourri of Child Neglect: Drug-exposure, Failure to Thrive, Medical Care. Forms of Neglect

Payment Policy: Urine Specimen Validity Testing Reference Number: CC.PP.056 Product Types: ALL Effective Date: 11/01/2017 Last Review Date:

What Can Dead People Tell Us? Postmortem Toxicology for Attorneys

BUPRENORPHINE-NALXONE 101

How many days does hydrocodone stay in your system

DrugConfirm Advanced Urine Dip Cards.

Figure 1. National Drug Overdose Deaths Number Among All Ages, by Gender,

Validation Report for the Neogen Fentanyl Kit for ELISA Screening of Whole Blood and Urine Specimens

Using Liquid Chromatography Tandem Mass Spectrometry Urine Drug Testing to Identify Licit and Illicit Drug-Use in a Community-based Patient Population

European Guidelines for Workplace Drug Testing in UrineandOral fluid

Dynacare Laboratories

Knowing Your Drugs. Drugs Defined. Substance Abuse. Substance Abuse: Substance Abuse: Stage One. Substance Abuse: Stage Three

3703 Camino del Rio South 100-A San Diego, CA, Phone Fax CLIA# 05D Director: David J.

Transcription:

Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences 12/13/2018 WELCOME! Today s Topic: Urine Drug Screens in OUD Treatment Should I test and how should I do drug testing in my patients on opioid use disorder treatment? Speaker: Jared Klein, MD, MPH PANELISTS: MARK DUNCAN, MD, RICK RIES, MD, KARI STEPHENS, PHD, AND BARB MCCANN, PHD

Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences URINE DRUG TESTING IN PATIENTS WITH OPIOID USE DISORDER JARED W KLEIN MD MPH UW SOM / HARBORVIEW

GENERAL DISCLOSURES The University of Washington School of Medicine also gratefully acknowledges receipt of educational grant support for this activity from the Washington State Legislature through the Safety-Net Hospital Assessment, working to expand access to psychiatric services throughout Washington State.

SPEAKER DISCLOSURES No financial disclosures Primary care internist integrated addiction treatment NOT a lab medicine specialist NOT discussing non-urine matrices NOT covering specialty settings or populations

OBJECTIVES After this talk learners will be able to 1. Name four potential justifications for employing urine drug testing 2. Understand at least two differences between screening and confirmatory urine testing 3. Identify common pitfalls of urine drug testing algorithms

OUTLINE Philosophy Tests Pitfalls

PHILOSOPHY Support diagnosis Evaluate progress in treatment Monitor for diversion Topic of conversation

PHILOSOPHY Support diagnosis

PHILOSOPHY Support diagnosis Monitor for diversion

PHILOSOPHY Support diagnosis Evaluate progress in treatment Monitor for diversion

PHILOSOPHY Support diagnosis Evaluate progress in treatment Monitor for diversion Topic of conversation

TESTS Immunoassay (aka ELISA) Amphetamine THC Opiate Cocaine PCP Benzodiazepine Methadone Oxycodone Others (fentanyl, bupe, barbiturate, etc.)

TESTS Gas chromotography/mass spectometry (GC/MS) ***Can detect dozens of unique substances***

TESTS Immunoassay GC/MS Cheap Expensive Rapid Slow More false positives/false negatives Accurate

TIPS & PITFALLS Test at least monthly Random urines preferred, but logistically difficult Always ask about anticipated results Last substance used, timing of last use Never order quantitative testing Expensive and rarely helpful Language matters Positive/negative preferred over clean/dirty

TIPS & PITFALLS All tests can provide in false positives Don t rely on a single test result! Common false positives Dextromethorphan opiate SSRIs amphetamines Sertraline benzodiazepines

TIPS & PITFALLS All tests can provide in false negatives Don t rely on a single test result! Common false negatives Benzodiazepine clonazepam, Z-drugs Amphetamine MDMA THC synthetic cannabinoids Opiates synthetic/semi-synthetic (next slide)

TIPS & PITFALLS Opioid metabolism Opiates (morphine, codeine, heroin) Semi-synthetic opioids (oxycodone) Synthetic opioids (fentanyl, methadone, bupe)

REFERENCES Appropriate Use of Drug Testing in Clinical Addiction Medicine (ASAM 2017) Drug Testing: A White Paper of the American Society of Addiction Medicine (ASAM 2013) URINE DRUG TESTING: A Reference Guide for Clinicians (Starrels and Wu, 2013) Office-Based Opioid Treatment Policy and Procedure Manual (Harborview, 2018)